Vitura Health Limited (ASX:VIT – Get Free Report) insider Robert Iervasi bought 179,200 shares of the stock in a transaction on Wednesday, September 4th. The shares were acquired at an average cost of A$0.08 ($0.06) per share, for a total transaction of A$15,052.80 ($10,035.20).
Vitura Health Price Performance
About Vitura Health
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for medicinal cannabis; CDA Clinics, which provides medicinal cannabis consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations.
Featured Stories
- Five stocks we like better than Vitura Health
- How to Evaluate a Stock Before BuyingÂ
- Why Block’s Key Components Make It a Solid Investment Choice
- Investing in the High PE Growth Stocks
- Is Applied Digital’s Stock Set to Surge With NVIDIA’s Backing?
- How to Invest in the FAANG Stocks
- 4 Reasons to Consider Adding General Mills to Your Portfolio
Receive News & Ratings for Vitura Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitura Health and related companies with MarketBeat.com's FREE daily email newsletter.
